PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Sep-2024 Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules AccessWire
18-Sep-2024 Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments AccessWire
18-Sep-2024 Afro Hair Transplant Clinic Recognized as One of the Top 10 Hair Transplant Clinics in Istanbul AccessWire
18-Sep-2024 Mann Eye Institute Celebrates 47 Years of Transforming Lives Through Vision AccessWire
18-Sep-2024 Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share Marinomed Biotech AG
18-Sep-2024 Bulgarian Academy of Sciences Issues Report on Results of Its In Vivo Testing of IPF as an Immunomodulator AccessWire
18-Sep-2024 Ready Doc(R) Rebrands to 'Incredable(TM)' With New Logo and Brand Identity After Revolutionizing Credentialing AccessWire
18-Sep-2024 Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement AccessWire
18-Sep-2024 Multi-Cancer Early Detection Market Forecast 2024-2034: Emerging Trends, Key Players, and Growth Opportunities Prophecy Market Insights
18-Sep-2024 Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador Mainz BioMed N.V.
18-Sep-2024 Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents AccessWire
18-Sep-2024 Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology AccessWire
18-Sep-2024 New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution Newswire
18-Sep-2024 New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution AccessWire
18-Sep-2024 Faro Health Joins Veeva Product Partner Program Newswire
18-Sep-2024 MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 Newswire
18-Sep-2024 Faro Health Joins Veeva Product Partner Program AccessWire
18-Sep-2024 MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing on Early Clinical Efficacy Demonstration for Neuropathic Pain in 2025 AccessWire
18-Sep-2024 Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis Immunic AG
18-Sep-2024 Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus AccessWire